GNT Pharma Co., Ltd.

Overview

GNT Pharma Co., Ltd. is a biopharmaceutical company based in South Korea focused on developing innovative therapies for neurodegenerative disorders. The company specializes in designing drugs that target multiple mechanisms responsible for brain diseases.

Therapeutic areas

API / Drug Master Files

GNT Pharma Co., Ltd. holds 5 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CABERGOLINEActive2017-10-13
• PENTOSAN POLYFULFATE SODIUMActive2016-10-17
• CISATRACURIUM BESYLATE VERSION FA1Active2012-08-27
• CISATRACURIUM BESYLATEActive2012-08-27
• METHOTREXATEActive2012-04-10
• PENTOSAN POLYSULFATE SODIUMInactive2009-05-15
• BICALUTAMIDE ADSORBATEInactive2008-11-04
• ATRACURIUM BESYLATEInactive2005-06-21
• TOPIRAMATEInactive2005-04-10
• BICALUTAMIDEInactive2005-03-03
• LAMOTRIGINEInactive2005-03-03

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GNT Pharma Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.